Consensus NICE Ltd. OTC Markets

Equities

NCSYF

IL0002730112

Market Closed - OTC Markets Other stock markets 07:23:39 15/05/2024 pm IST			5-day change	1st Jan Change
222.4 ^USD	+1.17%		+1.17%	+12.87%

03:50pm	NICE's Solid Q1 Overshadowed by Surprise CEO Transition, RBC Says	MT
03:13pm	Wedbush Adjusts NICE's PT to $250 From $270, Notes Potential Disruption to Business During CEO Transition; Keeps Outperform Rating	MT

Evolution of the average Target Price on NICE Ltd.

Price target over the last 5 years

History of analyst recommendation changes

5adb96d381def3110.0BpLqzSrzIrLXXFzQ1Ez3ULL9RVn1csHmilEglqZi-4.oV4D42Dx-Pj8CRgAET1LkA-mzFoQj403t1kF6XfxyLaBbBjCUtL5u50qEg~c01d42b565a9c3e688fdc76ed2515ce0

Analyst Recommendations on NICE Ltd.

Wedbush Adjusts NICE's PT to $250 From $270, Notes Potential Disruption to Business During CEO Transition; Keeps Outperform Rating	06:43pm	MT
JMP Securities Cuts Price Target on NICE to $300 From $343, Maintains Market Outperform Rating	05:49pm	MT
Mizuho Cuts Price Target on NICE to $280 From $300, Maintains Buy Rating	05:40pm	MT
RBC Cuts Price Target on NICE to $265 From $285, Says 'CEO Transition Represents Meaningful Risk,' Keeps Outperform Rating	04:11pm	MT
DA Davidson Upgrades NICE to Buy From Neutral, Adjusts Price Target to $300 From $250	13/03	MT
Mizuho Ups Price Target on NICE to $300 From $244, Keeps Buy Rating	23/02	MT
Barclays Raises NICE's Price Target to $320 From $283, Keeps Overweight Rating	23/02	MT
Oppenheimer Raises NICE Price Target to $300 From $225, Maintains Outperform Rating	23/02	MT
RBC Raises Price Target on NICE to $285 From $238, Keeps Outperform Rating	23/02	MT
Wedbush Raises NICE's PT to $270 From $230 After 'Strong' Q4 2023 Results, Keeps Outperform Rating	23/02	MT
Citigroup Adjusts NICE's Price Target to $334 From $283, Keeps Buy Rating	21/02	MT
Morgan Stanley Raises Price Target on NICE to $260 From $220, Keeps Overweight Rating	14/12	MT
Morgan Stanley Upgrades NICE to Overweight From Equalweight, Cuts Price Target to $220 From $225	16/23/16	MT
Oppenheimer Adjusts NICE Price Target to $225 From $250, Maintains Outperform Rating	05/23/05	MT
Citigroup Adjusts NICE Price Target to $338 From $278, Maintains Buy Rating	15/23/15	MT
William Blair Starts NICE at Outperform	26/23/26	MT
Mizuho Initiates NICE at Buy With $244 Price Target	31/23/31	MT
Jefferies Adjusts Price Target on NICE to $235 From $260, Keeps Buy Rating	12/23/12	MT
Wedbush Cuts NICE's Price Target to $230 From $250 Reflecting Lower Multiple, Keeps Outperform Rating	12/23/12	MT
Citigroup Adjusts Price Target on NICE to $278 From $277, Keeps Buy Rating	10/23/10	MT
Piper Sandler Upgrades NICE to Overweight From Neutral, Adjusts Price Target to $227 From $222	17/23/17	MT
RBC Capital Adjusts Price Target on NICE to $238 From $265, Maintains Outperform Rating	10/23/10	MT
Citigroup Adjusts Price Target on NICE to $260 From $254, Maintains Buy Rating	11/22/11	MT
Morgan Stanley Adjusts NICE's Price Target to $215 from $235, Retains Equalweight Rating	11/22/11	MT
Piper Sandler Starts NICE at Neutral With $236 Price Target	25/22/25	MT